Regular exercise, plasminogen activator inhibitor-1 (PAI-I) activity and the 4G/5G promoter polymorphism in the PAI-1 gene

被引:0
|
作者
Väisänen, SB
Humphries, SE
Luong, LA
Penttilä, I
Bouchard, C
Rauramaa, R
机构
[1] Univ Kuopio, Kuopio Res Inst Exercise Med, FIN-70100 Kuopio, Finland
[2] Univ Kuopio, Dept Physiol, FIN-70100 Kuopio, Finland
[3] UCLMS, Rayne Inst, Dept Med, Ctr Cardiovasc Genet, London, England
[4] Kuopio Univ Hosp, Dept Clin Chem, SF-70210 Kuopio, Finland
[5] Univ Laval, Phys Act Sci Lab, St Foy, PQ G1K 7P4, Canada
[6] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland
关键词
plasminogen activator inhibitor-1; DNA polymorphism; exercise training; randomised clinical trial; population based study;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this controlled randomised clinical trial was to investigate the effects of regular low to moderate intensity physical activity on plasminogen activator inhibitor-1 (PAI-1) activity during three years while taking into account the 4G/5G polymorphism in the promoter of the PAI-1 gene. Male subjects (age 52-62 years, n = 132) were randomised into an exercise or a (non-intervention) reference group. Aerobic threshold increased by 8.8% (p = 0.025) in the exercise group, and decreased by 1.1% in the non-intervention group, while PAI-1 activity did not change significantly in either study group. However! homo zygotes for the 4G allele in the exercise group showed a 36% reduction in PAI-1 (p = 0.025). In conclusion, although regular moderate physical activity did not decrease PAI-1 activity in the whole group, regular exercise ma) be effective for controlling elevated PAI-1 level in subjects homozygous for the 4G allele.
引用
收藏
页码:1117 / 1120
页数:4
相关论文
共 50 条
  • [11] The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels
    Sari, Esin Sogutlu
    Yazici, Alper
    Eser, Betul
    Erol, Muhammet Kazim
    Kilic, Adil
    Ermis, Sitki Samet
    Koytak, Arif
    Aksit, Hasan
    Yakut, Tahsin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (04) : 270 - 274
  • [12] Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
    Adriano de Paula Sabino
    Daniel Dias Ribeiro
    Caroline Pereira Domingueti
    Mariana Silva dos Santos
    Telma Gadelha
    Luci Maria SantAna Dusse
    Maria das Graças Carvalho
    Ana Paula Fernandes
    Molecular Biology Reports, 2011, 38 : 5355 - 5360
  • [13] Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
    Sabino, Adriano de Paula
    Ribeiro, Daniel Dias
    Domingueti, Caroline Pereira
    dos Santos, Mariana Silva
    Gadelha, Telma
    SantAna Dusse, Luci Maria
    Carvalho, Maria das Gracas
    Fernandes, Ana Paula
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (08) : 5355 - 5360
  • [14] The plasminogen activator inhibitor-1 (PAI-1) gene −844 A/G and −675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome
    Sun Lin
    Zhang Huiya
    Liu Bo
    Wei Wei
    Guan Yongmei
    Endocrine, 2009, 36 : 503 - 509
  • [15] Plasminogen activator inhibitor-1 (PAI-1) level and 4G/5G genetic polymorphism in patients with colorectal cancer
    Blasiak, J
    Smolarz, B
    Kubryn, I
    Kulig, A
    Dziki, A
    Ulanska, J
    Pander, B
    EXPERIMENTAL ONCOLOGY, 2000, 22 (1-2): : 48 - 51
  • [16] The 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with myocardial infaction (MI) in Chinese patients.
    Han, ZC
    An, XG
    Wang, PX
    Zhou, YL
    Wu, HZ
    You, HW
    BLOOD, 2000, 96 (11) : 96B - 96B
  • [17] Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels
    Matsubara, Y
    Murata, M
    Isshiki, I
    Watanabe, R
    Zama, T
    Watanabe, G
    Watanabe, K
    Ikeda, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (01) : 43 - 47
  • [18] Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene
    Panahloo, A
    Mohammad-Ali, V
    Gray, RP
    Humphries, SE
    Yudkin, JS
    ATHEROSCLEROSIS, 2003, 168 (02) : 297 - 304
  • [19] Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children
    Berberoglu, M.
    Evliyaoglu, O.
    Adiyaman, P.
    Öcal, G.
    Ulukol, B.
    Simsek, F.
    Siklar, Z.
    Törel, A.
    Özel, D.
    Akar, N.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (05): : 741 - 748
  • [20] Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population
    Shammaa, Dina M. R.
    Sabbagh, Amira S.
    Taher, Ali T.
    Zaatari, Ghazi S.
    Mahfouz, Rami A. R.
    MOLECULAR BIOLOGY REPORTS, 2008, 35 (03) : 453 - 457